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Jeanette Kusel1*, Beth Timm1 and Ian Lockhart2Abstract
Smoking in the home remains a key source of exposure to secondhand smoke for non-smokers, particularly since
the UK public smoking ban in 2007. A systematic literature review was conducted to identify all UK evidence on the
impact of secondhand smoke exposure in the home on health and behavioural outcomes in non-smoker
occupants. MEDLINE, EMBASE and the Cochrane Library were searched to identify all relevant UK empirical studies
from 2000 to June 2011. A qualitative overview of the evidence is presented. Exposure to secondhand smoke in UK
homes was found to be associated with serious negative health effects in non-smokers, including significantly
increased risk of meningococcal carriage (p < 0.001) and disease (p = 0.05) in children and adolescents, cognitive
impairment (p < 0.001) in adults, a higher rate of medically attended accidents in children with smoking mothers
(p < 0.01), and for non-smoking women, a significant decrease in infant birth weight (p = 0.007). Living in a smoking
household significantly increased the risk of future regular smoking in children (p < 0.001). In conclusion, this
systematic review has identified strong evidence of an association between secondhand smoke exposure in the
home and several serious health conditions. This finding highlights the importance of educating current smokers
on the consequences of non-smoker exposure to smoking in the home.
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Secondhand smoke (SHS) is the smoke from the burning
tip of a cigarette or exhaled smoke that is then inhaled
by non-smokers. On a global scale, SHS was responsible
for an estimated 600,000 deaths of non-smokers in 2011,
the majority of which were women and children [1].
SHS exposure has been hailed as one of the world’s most
critical environmental health hazards and there is no
reported safe level of exposure [1]. SHS is known to be
associated with an increased risk of smoking-related
diseases such as lung cancer, heart disease, respiratory
infection and meningitis [2-6].
In the UK, 21% of the population were smoking in
2010 [7]. The smoking ban in the UK has successfully
reduced smoking in public places, work places, restau-
rants and bars, with some evidence of an improvement
in health outcomes [8-10]. However, non-smokers living
in smoking households continue to be exposed to high* Correspondence: jeanette.kusel@costellomedical.com
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reproduction in any medium, provided the orlevels of SHS in the home and therefore passive expos-
ure remains a major public health issue, particularly for
children [11,12]. In 2007, 22% of children aged 4–15 in
the UK lived in a home where someone smoked indoors
[12]. Where one parent smoked, this parent did so inside
the home in 63% of cases and where both parents
smoked at least one of them did so inside the home in
79% of cases [12].
The main objective of this review was to collate the
current UK evidence on the impact of exposure to SHS in
the home on health outcomes of non-smoker occupants.
Within this main objective, the review was divided into two
distinct areas with the aim of assessing: (1) health outcomes
of non-smokers previously and currently exposed to SHS in
the home; and (2) risk of current or future smoking in chil-
dren exposed to second hand smoke in the home.Methods
Systematic review methods
A systematic and comprehensive literature search was con-
ducted to identify all empirical studies that considered ad-
verse events associated with exposure to SHS in the home,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ting. Studies reporting on home smoking were obtained
through text word searches relating to ‘house’, ‘home’ or ‘do-
mestic’, and combined with the MeSH headings ‘Tobacco
Smoke Pollution’, ‘Smoking’, ‘Smoking Cessation’ and
‘Tobacco Use Cessation’ and relevant text word searches,
including search terms for smoking related toxins/particles.
Using these search strategies, the MEDLINE (including
MEDLINE In Process), EMBASE and Cochrane Library
databases were searched to June 2011. Search results were
restricted from the year 2000 to ensure that only contem-
porary data on exposure and morbidity were used to in-
form the review.
Inclusion and exclusion criteria
A single assessor reviewed the titles and abstracts of all
search results and identified empirical studies specifically
addressing: (1) the impact of past or current SHS exposure
in the home on the health outcomes of non-smokers; and
(2) the impact of home exposure as a child on the risk
of future smoking behaviour. Studies were limited to the
UK only.
Studies of low quality were excluded; low quality was
defined as a score of 3 or less on the Newcastle Ottawa
scale or admission by the study authors that it was under-
powered for the outcomes of interest. A second, inde-
pendent assessor reviewed all studies deemed potentially
relevant by the first reviewer and confirmed inclusion.
Disagreement between the reviewers was resolved through
arbitration by a third party.
The study characteristics, population demographic data
and outcomes of interest were extracted systematically
from each included study by one reviewer and verified by a
second, independent reviewer. Due to the differing popula-
tions across included studies and variation in the outcomes
extracted across the research objectives, it was not possible
to combine the results using statistical analysis; a qualitative
description of outcomes of interest is given in the results.
Assessment of study quality
All studies that met the inclusion criteria were critically
appraised using the Newcastle-Ottawa scale, as recom-
mended by the Cochrane collaboration for use with non-
randomised, empirical studies [13]. This scale assesses the
methodological quality of studies based on three categor-
ies: selection of the cohort of interest, comparability of the
cohorts, and assessment of the outcomes of interest (for
cohort studies) or the assessment of exposure (for case–
control studies). The optimal assessment of exposure to
SHS was considered to be measurement of cotinine levels
in blood or saliva, as patient and parent-reported mea-
sures of SHS exposure often underestimate the extent of
exposure, due to inaccurate reporting of smoking behav-
iour [14,15].Results
The literature searches identified 4151 individual cita-
tions once duplicates were removed, and of these 4090
were excluded on title or abstract. After full-text review
of the remaining 51 articles, 33 were found to be rele-
vant to the review objectives but 10 of these were
excluded for low quality or lack of power; therefore 23
UK studies were included in the review (Figure 1).
The key characteristics for all 23 included studies pertain-
ing to all search objectives are given in Table 1. Further
details of the 10 studies excluded for their low quality or
lack of statistical power are given in the Additional file 1:
Table S1.
The impact of past and current exposure to secondhand
smoke in the home
There were 21 UK studies of sufficient quality that assessed
risk of illness or accidents related to past or current expos-
ure to SHS in the home. Of these, 10 were longitudinal
cohort, 4 were case control, and 7 were cross-sectional
studies. Methodological details of the studies are presented
in Table 1. All longitudinal studies scored 6 or above out of
a possible 9 on the Newcastle-Ottawa scale. The highest de-
gree of variability for all types of study was the lack of ap-
propriate measure of SHS exposure [16,28,32,35,36]. The
results are described below in alphabetical order of health
condition.
Accidents
A large longitudinal cohort study of 11,332 children that
followed them from birth to age 5 identified a significantly
higher risk of accidents in children whose mothers smoked
over the 5 year time period, for all accidents and medically
attended accidents (Table 2) [16].
Asthma and respiratory symptoms
Eleven studies were included that reported on the asso-
ciation of SHS exposure (past or current) with asthma
and other respiratory symptoms. Two additional studies
reported on the association of exposure to SHS with the
use of the healthcare system by asthmatic children.
Of the 6 studies identified that reported on non-
smokers who have been exposed to SHS in the home in
the past, 5 reported results from the Isle of Wight birth
cohort study. The Isle of Wight birth cohort study was a
prospective study to indentify risk factors relevant to
wheezing and asthma. Of 1536 children born on the Isle
of Wight between January 1st 1989 and February 28th
1990, 1456 children were enrolled. Enrolment took place
at birth with information on family history of allergies,
household pets, smoking habits, birth weight and social
class being recorded. The children were followed up at
the ages of 1, 2, 4 and 10 years [17-21]. In the sub-study
of all children included at the 10 year assessment,
4151 individual citations after
exclusion of duplicates
Search Objective 1
45 full text UK articles
assessed for eligibility
Search Objective 2
6 full text UK articles 
assessed for eligibility











21 UK studies included
in review




2 did not report on the prevalence/risk of 
smoking
1 low quality study (<3 NO scale)
24 studies excluded
4 systematic reviews
1 did not specifically discuss SHS in the 
home
7 did not report on illness/accidents
3 did not include UK participants
7 low quality studies (<3 NO score)
2 lack of statistical power
Figure 1 Flow diagram of included and excluded studies.
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with currently diagnosed asthma at age 10 (OR = 1.99
[95% CI 1.15-3.45]; p = 0.014) and parental smoking at
age 4 was found to be significantly associated with
current wheeze at age 10 (OR = 2.18 [95% CI 1.25-3.81];
p = 0.006; Table 2) [17]. Parental smoking at birth, 1 year,
2 years and 4 years was significantly associated with
early-onset persistent wheeze (Table 2) [19,20]. Symp-
tom expression in bronchial hyper-responsiveness, a
hallmark of asthma, at 10 years was also significantly
associated with parental smoking at age 4 (Table 2) [18].
However, no significant association was found between
exposure to SHS in the home in early childhood (birth
to 4 years) and respiratory allergic outcomes at 4 years
old (Table 2) [21]. In a separate prospective cohort
study, maternal smoking in the home at 30 months was
associated with a significantly increased likelihood of any
wheeze (OR = 2.04 [95% CI 1.10-3.81]; p = 0.024) and
exercise-induced wheeze (OR = 2.14 [95% CI 1.11-4.12];
p = 0.022), but not night cough (OR 1.62 [95% CI 0.91-2.87];
p = 0.098), at 6 years (Table 2) [22]. These studies indicate
how past smoking behaviour can be associated with future
poor respiratory health.
Five studies were identified that reported on the asso-
ciation between current exposure to SHS in the homeand asthma or respiratory symptoms. However, it should
be noted that causality between current exposure and
respiratory symptoms cannot be shown, as prior expos-
ure and other factors may have influenced the health
outcomes. In a cohort of high risk children where both
parents demonstrated a predisposition toward develop-
ing allergic hypersensitivity there were increased odds of
reporting wheeze ever and in the first year of life in chil-
dren whose mother had smoked postnatally (wheeze
ever: OR = 1.93 [95% CI 1.10-3.38]; p = 0.02, wheeze in
first year of life: OR = 1.79 [95% CI 1.05-3.08]; p = 0.03;
Table 2) [23]. In a large cross-sectional survey of a random
sample of adults, those exposed to SHS in the home were
significantly more likely to report severe respiratory symp-
toms compared to those with no exposure [24], whilst two
other cross-sectional studies also showed a non-significant
decrease in lung function associated with an increase in
exposure to SHS in the home (Table 2) [25,26]. However,
in a case control study that examined the difference in
concentrations of indoor pollutants in the homes of
children with asthma (cases) and those without (controls),
no significant difference in concentrations of any indoor
pollutant, including SHS specific particles, was
found between asthma case and control environ-
ments (Table 2) [27].
Table 1 Overview of the main characteristics for UK studies that report evidence on the impact of SHS exposure in the
home on health and behavioural outcomes in non-smoker occupants





























1,373 Completed 10 year assessment 6
Kurukulaaratchy
et al. 2003 [18]
169 Positive for bronchial hyper-responsiveness at age 10 6
Kurukulaaratchy
et al. 2004 [19]
206 Early or late onset persistent wheeze at age 10 6
Kurukulaaratchy
et al. 2006 [20]
340 Reported wheeze ever up to age 10 with atopic parents 6
Tariq et al.
2000 [21]
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13919 Adolescent (15–19 years) Patient interview Meningococcal carriage 6
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Table 1 Overview of the main characteristics for UK studies that report evidence on the impact of SHS exposure in the
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N-O Score, Newcastle-Ottawa score(Wells et al.). A higher score indicates higher methodological quality; max. 9.
RSP, respirable suspended particle; VOC, volatile organic compound.
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tween asthma patients’ Accident and Emergency (A&E)
attendance and exposure to SHS in UK homes [28].
However, another cross-sectional study found that in
asthmatic children, a reduction in the rate of health ser-
vice contacts was significantly associated with increased
number of cigarettes smoked in the home (Table 2) [29].
The explanation given by the study authors for the
observed fewer health service contacts was that heavy
smoking may reduce the awareness of parents to the child’s
asthmatic symptoms.
Birth outcomes
One large retrospective birth cohort study demonstrated
that for SHS exposed non-smoking mothers, there was a
significant decrease in the crude and adjusted mean birth
weight of their offspring compared to non SHS exposed
mothers (crude mean difference: -0.059 kg, p < 0.001;
adjusted mean difference: -0.036 kg, p = 0.025) [30]. Ex-
posure to SHS was also associated with non-significant
increases in the incidence of premature births (Table 2).
Bone characteristics
A longitudinal birth cohort study found that paternal
smoking during pregnancy at weeks 18 and 32 was asso-
ciated with a significant increase in total body-less-head
bone area in girls but not boys at age 10 (Table 2) [31].
The main conclusion made by the authors was that the
significant influence that paternal smoking factors had on
girls’ health outcomes, combined with non-significant ma-
ternal smoking outcomes, could indicate that these asso-
ciations are largely driven by familial characteristics
related to childhood, and are unlikely to be due to intra-
uterine mechanisms.
Breast cancer
A UK case–control study of women aged 36–45 years
who were diagnosed with invasive breast cancer reportedno increased risk of breast cancer associated with expos-
ure to SHS in the home through partner smoking
(Table 2) [32].
Cognitive impairment
A large, cross-sectional study conducted in a cohort of
non-smoking adults over 50 years of age identified a
statistically significant increased odds of cognitive impair-
ment associated with rising saliva cotinine levels in non-
smokers (p = 0.02 for trend; OR = 1.44; Table 2) [33].
Dental caries
A cross-sectional survey demonstrated a significant in-
crease in the odds of caries in pre-school children who
had a smoking mother and were from families who had
manual occupations (Table 2) [34].
Meningitis carriage and disease
Two studies, one case control and one longitudinal,
were identified that reported an association between
SHS exposure in the home and a significantly increased
likelihood of meningococcal carriage and disease in ado-
lescents, respectively [35,36]. Exposure to other smokers
in the home was a significant factor for a positive test
for meningococcal carriage according to a multivariable
analysis (Table 2) [35]. Exposure to smokers was also
found to be significantly and independently associated
with meningococcal disease (Table 2), but this associ-
ation is likely to be due to higher carriage rates in smo-
kers rather than SHS exposure [36].
The impact of secondhand smoke exposure on smoking
behaviour
Summary of relevant studies
Only 2 UK studies were identified for inclusion that dis-
cussed the impact of exposure as a child on the risk of
current or future smoking behaviour [37,38]. Of these
studies, 1 was longitudinal, which scored the maximum
Table 2 Health outcomes of non-smokers exposed to SHS in the home









For maternal smoking vs. non-smoking:
All accidents RR 1.17, 95% CI 1.12-1.23 <0.01
Medically attended accidents RR 1.23, 95% CI 1.14-1.32 <0.01
Asthma and Related Symptoms
Isle of Wight Birth Cohort
Arshad et al.
2005 [17]
1,373 Asthma at age 10 by parental smoking at age 1 vs. non-smoking OR 1.99; 95% CI 1.15-3.45, 0.014
Wheeze at age 10 by parental smoking at age 4 vs. non-smoking OR 2.18; 95% CI 1.25-3.81 0.006
Kurukulaaratchy
et al. 2003 [18]
169 Bronchial hyper-responsiveness at 10 years by parental smoking at
age 4 vs. non-smoking
OR 2.62, 95% CI 1.03-6.71 0.04
Kurukulaaratchy
et al. 2004 [19]

















OR 2.25, 95% CI 1.52-3.32 <0.001
Kurukulaaratchy
et al. 2006 [20]
340 Wheeze ever vs. no parental smoking by parental
smoking at
1 years








OR 1.80, 95% CI 1.25-2.58 0.001
Tariq et al.
2000 [21]
1,218 Asthma at 4 years by exposure to SHS in the home in early childhood
vs. no exposure
OR 1.2, 95% CI 0.3-2.7 NR
Any allergic hypersensitivity at 4 years by exposure to SHS in the
home in early childhood vs. no exposure




219 Any wheeze at 6 years by exposure at 30 months vs. no exposure OR 2.04, 95% CI 1.10-3.81 0.024
218 Exercise-induced wheeze at 6 years by exposure at 30 months vs. no
exposure
OR 2.14, 95% CI 1.11-4.12 0.022
219 Night cough at 6 years by exposure at 30 months vs. no exposure) OR 1.62, 95% CI 0.91-2.87 0.098
Murray et al.
2004 [23]
369 For mother smoking postnatally vs. non-smoking










2996 Severe respiratory symptoms OR 1.4, 95% CI 1.0-1.8 NR
Chen et al.
2001 [25]
301 Lung function: mean residuals of FEV1 and FVC NR >0.05
Palmer et al.
2006 [26]
504 Lung function NR >0.05
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Table 2 Health outcomes of non-smokers exposed to SHS in the home (Continued)
Gee et al.
2005 [27]
95 controls Difference in indoor pollutant levels between asthma cases and
controls















Health service contacts for asthma by number of
cigarettes smoked by parent per day (compared to
0–5)




11-15 IRR 0.70, 95% CI 0.59-0.83
16-20 IRR 0.74, 95% CI 0.61-0.91
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OR 1.08, 95% CI 0.78-1.48 0.02 for trend
Third quartile
cotinine level
OR 1.13, 95% CI 0.81-1.56
Fourth quartile
cotinine level












OR 1.55, 1.02–2.35 <0.05
Meningitis Carriage and Disease
MacLennan et al.
2006 [35]
13,919 Meningococcal carriage in exposed (n = 5064) OR 1.17, 95% CI 1.05-1.30 0.004
vs. non-exposed (n = 8547)
Coen 2006 [36] 144
survivors




A&E, accident and emergency; CI, confidence interval; IFEV, forced expiratory volume; FVC, forced vital capacity; RR, incidence rate ratio; NA, not appropriate; NR,
not reported; OR, odds ratio; RR, risk ratio; TBLH, total body less head.
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a cross-sectional cohort study scoring 4. The key out-
comes assessed were different frequencies of smoking:
ever having tried smoking or daily smoking [37,38].Impact on smoking behaviour
A longitudinal study found that significantly more chil-
dren aged 10 and 11 had tried smoking if they lived with
a smoker (p < 0.001; Table 3) compared to those who
lived in a non-smoking household [37]. There was also a
significant association between having tried smoking and
living with a mother or sibling who smokes (Table 3)
[37]. Exposure to SHS was not, however, found to be sig-
nificantly associated with smoking behaviour [37]. A
cross-sectional survey in Scotland and Wales also found
that the presence of a parent smoker or other smoker
was associated with a significantly increased likelihood
of being a daily smoker compared with neither parent
smoking or living with no smokers (p < 0.001 for all ana-
lyses; Table 3) [38].
Regarding future smoking, a logistic regression ana-
lysis from the longitudinal study found that having a
father or brother who smoked when aged 9 meant that
the child was over 5 times more likely to try smoking byTable 3 Risk of future smoking in children exposed to second
Study ID Behaviour outcome
Milton et al. 2004
[37]
Ever tried smoking:
Currently exposed to smokers in the home vs.
non-smokers
Currently exposed to SHS in the home vs. not
exposed
Tried smoking by age 11:
Exposed to smoking father at age 9
vs. non-smoking father












CI, confidence interval; NR, not reported; OR, odds ratio.age 11 than those who did not have a smoking father or
brother at age 9 (Table 3) [37].Discussion-conclusions
Empirical UK evidence identified in this review has
demonstrated that there are significant negative health
outcomes associated with SHS exposure in the home,
such as asthma, meningococcal disease, cognitive im-
pairment, and dental caries.
In addition to the potential negative impact on health
outcomes, SHS exposure in the home also seems to be
related to smoking behaviour, particularly in children and
adolescents. A significant proportion of children and ado-
lescents in the UK who live in smoking households have
tried smoking themselves, and living in a smoking house-
hold has been shown to be associated with an increased
likelihood of regular smoking in the future [37,38]. Interest-
ingly, time spent in a ‘smoky environment’ was not asso-
ciated with ever trying smoking, although the same study
showed that living with a smoker significantly increased the
probability of ever trying smoking [37]. This suggests that
the influence of smoking in the home is not only related to
SHS exposure in itself; even if smoking members of the
house are careful to smoke out of the direct environmenthand smoke in the home

















NR OR 5.27, 95% CI 2.18 – 12.74 0.002
NR OR 5.32, 95% CI 1.36 – 21.18 0.017
both
1635 OR 1.73, 95% CI 1.32-2.26 <0.001
1364 OR 1.98, 95% CI 1.46-2.70 <0.001
arent)
1635 OR 2.43, 95% CI 1.84-3.22 <0.001
1364 OR 2.11, 95% CI 1.47-3.02 <0.001
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influence that encourages children to take up smoking.
The strengths of this review include the comprehen-
sive search strategy, systematic data extraction and
robust quality assessment method employed. The limita-
tion of the review to UK studies reduced heterogeneity
between study populations, but may have meant that
other potential risks associated with SHS exposure in
the home that have been identified outside of the UK
will have been missed. The generalisability of the review
results to countries outside of the UK is also unclear, al-
though it is likely that the results will be relevant to
countries that have had a smoking ban in public places
for a similar length of time as the UK. There are several
other limitations to this review, particularly due to the
varied design of the studies that were included; the stud-
ies were often not comparable in terms of measurement
of exposure to SHS or definition of health outcomes.
The quality of each study was individually assessed using
the Newcastle-Ottawa scale, and conclusions of the re-
view have been limited to statements based on a good
quality evidence base. Due to the difficulty of proving a
causal link between SHS and health outcomes, most of the
studies that were included reported statistical associations.
This review was limited to second hand smoke expos-
ure only, but in addition to second hand exposure to
smoke in the air there is also a risk of ‘third hand’ ex-
posure, which refers to the residual tobacco smoke parti-
cles that remain after a cigarette is extinguished [39].
Children are highly susceptible to the ingestion of these
third hand smoke particles [40]. Research conducted in
the USA has shown that in smoking households high
levels of surface nicotine can persist for several months
even when smoking has ceased [41,42].
In summary, a review of the UK data on the impact of
exposure to SHS in the home on health outcomes of
non-smoker occupants has demonstrated a significantly
increased probability of many negative health outcomes.
Furthermore, smoking in the home appears to influence
the future smoking behaviours of non-smokers. It is un-
clear how knowledgeable smokers are on the effects of
smoking in the home, but the implication of this review
is that it is essential that people who currently smoke in
their home, particularly those with children or with a
pregnant partner, are made aware of the potential impact
of their smoking behaviour on non-smokers. Current
smokers should be given adequate support to assist
them in stopping smoking and reducing exposure of
non-smokers to SHS within their home, which could in-
clude both counselling and access to pharmacotherapy.
The evidence from this review lends support to the ra-
tionale and objectives of campaigns such as The Smoke
Outside campaign from Smoke Free South West [43]
and the Take 7 Steps Out campaign in the North East ofthe UK [44], both of which aim to educate people on the
potential dangers of smoking in the home and to provide
encouragement for people to smoke outside.
Additional file
Additional file 1: Table S1. Overview of the main characteristics for
additional studies that report UK evidence on the impact of SHS exposure
in the home on health and behavioural outcomes in non-smoker
occupants not discussed in the main body of the manuscript.
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